Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel

Por Klipping, Christine, Duijkers, Ingrid, Parke, Susanne, Mellinger, Uwe, Serrani, Marco, Junge, Wolfgang
Publicado em 2012

Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study

Por Klipping, Christine, Duijkers, Ingrid, Fortier, Michel P, Marr, Joachim, Trummer, Dietmar, Elliesen, Jörg
Publicado em 2012

Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study

Por Klipping, Christine, Duijkers, Ingrid, Fortier, Michel P, Marr, Joachim, Trummer, Dietmar, Elliesen, Jörg
Publicado em 2012

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study

Por Duijkers, Ingrid J.M., Klipping, Christine, Zimmerman, Yvette, Appels, Nicole, Jost, Maud, Maillard, Catherine, Mawet, Marie, Foidart, Jean-Michel, Coelingh Bennink, Herjan J. T.
Publicado no Eur J Contracept Reprod Health Care (2015)